Guideline Therapeutics and COVID-19: living guideline
NORTH SAILS 603154 - Parka
XXXVII Congreso SETH 2021.indd
EL VALOR DEL MEDICAMENTO DESDE UNA PERSPECTIVA SOCIAL
RESÚMENES DEL XLII CONGRESO DE LA SOCIEDAD ESPAÑOLA DE NEFROLOGÍA Y VII IBEROAMERICANO DE NEFROLOGÍA
Molecular characteristics, immune evasion, and impact of SARS-CoV-2 variants | Signal Transduction and Targeted Therapy
Molecules | Free Full-Text | Strategies Tackling Viral Replication and Inflammatory Pathways as Early Pharmacological Treatment for SARS-CoV-2 Infection: Any Potential Role for Ketoprofen Lysine Salt?
Monoclonal antibody therapies against SARS-CoV-2 - The Lancet Infectious Diseases
Engineered extracellular vesicles directed to the spike protein inhibit SARS-CoV-2: Molecular Therapy - Methods & Clinical Development
XXXVII Congreso SETH 2021.indd
Frontiers | The Mechanism of Lung and Intestinal Injury in Acute Pancreatitis: A Review
NAPAPIJRI Rainforest Winter - Jacket
Guideline Therapeutics and COVID-19: living guideline
RESÚMENES DEL XLII CONGRESO DE LA SOCIEDAD ESPAÑOLA DE NEFROLOGÍA Y VII IBEROAMERICANO DE NEFROLOGÍA
Optimized ACE2 decoys neutralize antibody-resistant SARS-CoV-2 variants through functional receptor mimicry and treat infection in vivo | Science Advances
Emergence of the E484K mutation in SARS-COV-2-infected immunocompromised patients treated with bamlanivimab in Germany - The Lancet Regional Health – Europe
Advances in Nanomaterial-Based Platforms to Combat COVID-19: Diagnostics, Preventions, Therapeutics, and Vaccine Developments | ACS Applied Bio Materials
Structural basis of SARS-CoV-2 Omicron immune evasion and receptor engagement | Science
Pre-existing Reactivity to an IgG4 Fc-Epitope: Characterization and Mitigation of Interference in a Bridging Anti-drug Antibody Assay | SpringerLink
Monoclonal antibodies targeting two immunodominant epitopes on the Spike protein neutralize emerging SARS-CoV-2 variants of concern - eBioMedicine
XXXVII Congreso SETH 2021.indd
Targeting the Epidermal Growth Factor Receptor with Molecular Degraders: State-of-the-Art and Future Opportunities | Journal of Medicinal Chemistry
RESÚMENES DEL XLII CONGRESO DE LA SOCIEDAD ESPAÑOLA DE NEFROLOGÍA Y VII IBEROAMERICANO DE NEFROLOGÍA
EL VALOR DEL MEDICAMENTO DESDE UNA PERSPECTIVA SOCIAL
PI16 attenuates response to sorafenib and represents a predictive biomarker in hepatocellular carcinoma - Wang - 2020 - Cancer Medicine - Wiley Online Library
Comunicaciones orales
